Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $52.40.

A number of equities analysts recently weighed in on ESTA shares. Needham & Company LLC upgraded Establishment Labs from a “hold” rating to a “buy” rating and set a $48.00 price target for the company in a research report on Wednesday, May 14th. Stephens reaffirmed an “overweight” rating and issued a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Wall Street Zen lowered shares of Establishment Labs from a “hold” rating to a “sell” rating in a research report on Thursday, May 22nd. Finally, BTIG Research started coverage on Establishment Labs in a report on Friday, May 16th. They set a “buy” rating and a $62.00 target price on the stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Quarry LP acquired a new position in shares of Establishment Labs in the fourth quarter valued at $27,000. R Squared Ltd bought a new stake in Establishment Labs during the 4th quarter worth about $36,000. ANTIPODES PARTNERS Ltd bought a new stake in Establishment Labs during the 1st quarter worth about $81,000. KLP Kapitalforvaltning AS acquired a new position in Establishment Labs during the 4th quarter valued at about $161,000. Finally, Elevation Point Wealth Partners LLC bought a new position in shares of Establishment Labs in the 1st quarter valued at about $207,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Stock Down 0.1%

ESTA opened at $38.00 on Tuesday. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The stock’s fifty day moving average is $33.51 and its 200-day moving average is $37.52. Establishment Labs has a one year low of $26.56 and a one year high of $52.41. The company has a market capitalization of $1.10 billion, a PE ratio of -14.73 and a beta of 0.74.

Establishment Labs (NASDAQ:ESTA) last released its earnings results on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.13. The business had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The business’s quarterly revenue was up 11.3% on a year-over-year basis. During the same period in the prior year, the business earned ($0.58) earnings per share. On average, equities analysts predict that Establishment Labs will post -2.41 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.